Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05327647
Title A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer (BicaBCa)
Acronym BicaBCa
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors CHU de Quebec-Universite Laval
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.